- Home
- AMSC vs DYN Comparison
AMSC vs DYN Comparison
Compare AMSC & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMSC
- DYN
- Stock Information
- Founded
- AMSC 1987
- DYN 1984
- Country
- AMSC United States
- DYN United States
- Employees
- AMSC N/A
- DYN N/A
- Industry
- AMSC Metal Fabrications
- DYN Medicinal Chemicals and Botanical Products
- Sector
- AMSC Consumer Discretionary
- DYN Health Care
- Exchange
- AMSC Nasdaq
- DYN Nasdaq
- Market Cap
- AMSC 2.4B
- DYN 1.9B
- IPO Year
- AMSC 1991
- DYN 2020
- Fundamental
- Price
- AMSC $56.59
- DYN $12.86
- Analyst Decision
- AMSC Strong Buy
- DYN Strong Buy
- Analyst Count
- AMSC 3
- DYN 14
- Target Price
- AMSC $33.67
- DYN $34.93
- AVG Volume (30 Days)
- AMSC 917.6K
- DYN 2.3M
- Earning Date
- AMSC 10-29-2025
- DYN 11-11-2025
- Dividend Yield
- AMSC N/A
- DYN N/A
- EPS Growth
- AMSC N/A
- DYN N/A
- EPS
- AMSC 0.39
- DYN N/A
- Revenue
- AMSC $254,886,000.00
- DYN N/A
- Revenue This Year
- AMSC $23.00
- DYN N/A
- Revenue Next Year
- AMSC $14.44
- DYN N/A
- P/E Ratio
- AMSC $143.33
- DYN N/A
- Revenue Growth
- AMSC 63.73
- DYN N/A
- 52 Week Low
- AMSC $13.98
- DYN $6.36
- 52 Week High
- AMSC $58.42
- DYN $37.08
- Technical
- Relative Strength Index (RSI)
- AMSC 65.88
- DYN 53.16
- Support Level
- AMSC $47.52
- DYN $12.62
- Resistance Level
- AMSC $57.30
- DYN $13.68
- Average True Range (ATR)
- AMSC 2.66
- DYN 0.69
- MACD
- AMSC 0.43
- DYN -0.16
- Stochastic Oscillator
- AMSC 93.45
- DYN 13.91
About AMSC American Superconductor Corporation
American Superconductor Corp generates the ideas, technologies, and solutions that meet the world's demand for smarter, cleaner, and energy. Through its Windtec Solutions, the company enables manufacturers to launch wind turbines quickly, effectively, and profitably. Through its Gridtec Solutions, the company provides engineering planning services and grid systems that optimize network reliability, efficiency, and performance. The company's segment includes Grid and Wind. It generates maximum revenue from the Grid segment.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.